To further facilitate the utility of CRP kinetics in patient stratification and the prediction of treatment responses in future clinical practice, additional studies are required to investigate the potential associations among baseline CRP levels, distinct post-immunotherapy CRP kinetic patterns, and the composition of the tumour microenvironment. This evidence concerns the gene CRP and neoplasm.